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Dendritic cellsAbstract Immune system (IS) is comprised of molecules, cells, tissues and organs involved in host
defense mechanism from infectious agents or tumor cells. On crossing the cell barriers by these
infectious agents, the defense mechanism is alerted by the immune system to respond against these
invading microbes. Innate immune response (IIR) and acquired immune response (AIR) are work-
ing in parallel to control these invading microbes. IIR is composed of various types of phagocytes
and lymphocytes, while AIR is comprised of T and B lymphocytes. All the cells of the immune sys-
tem cooperatively work against infectious agents and cancerous cells but Natural killer (NK) cells
are playing an important role to respond to tumor by enhancing the expression of complementary
domain (CD86) on dendritic cells (DCs) and production of IL-12. NK cells demolished tumor
through perforin and granzyme, which are important for immune surveillance and death of tumor
cells induced by cytokines such as tumor necrosis factor (TNF), Fas ligand (CD178), interferon-c
(IFN-c) and IL-10. These cytokines have inhibited proliferation of tumor by inducing anti-
angiogenic factors and maintaining cross talk with other immune cells. Natural products like trans-
fer factor plus, immune modulator mix, ascorbic acid, Ganoderma lucidum, Agaricus blazei teas,
nitrogenated soy extract, Andrographis paniculata and several phytochemicals enhanced the
efficiency of NK cells in controlling cancers. Further studies will unravel the impact of NK cells
in cancer control and how NK efficiency can be further enhanced.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Immune system (IS) is a network of a population of molecules,
cells, tissues and organs to protect the body from microbes like
viruses, bacteria and other toxins. When microbes cross the
natural cell barriers, the IS alerts the defense mechanism of
the body and activates different types of cells to respond to
these invading microbes to protect the health of the organism.
The IS naturally has the ability to protect and heal the body
and to prevent various diseases. A healthy IS increases the
ability of the body to defend against various pathogens,
microbes, decreases infection rate, allows efficient healingFigure 1 Type of immune system and variouand improves quality of health [1]. The immune system is
dependent on two types of immunities; innate immune
response (IIR) and acquired immune response (AIR). The
IIR is a second line of defense because it acts against invaders,
who cross the physical barriers such as skin and mucosa. IIR is
comprised of various phagocytes such as Natural killer cells,
dendritic cells, macrophages, neutrophils, basophils and eosi-
nophils (Fig. 1). Natural killer cells are involved in the destruc-
tion of tumor and virus-infected cells, while the dendritic cells,
macrophages, basophils, eosinophils and neutrophils mediate
the inflammatory response which is immediate but of short
term. These cells also act as physical or chemical barriers tos immune cells involved in defense system.
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ease. These cells phagocytose the pathogens or foreign invad-
ing microbes and help in their elimination. IIR requires no
special preparation to act against pathogens and consists of
chemical, mechanical, microbiological and cellular defense net-
works. IIR’s function is to stop and return the foreign particles
at the entry sites. AIR is an adaptive immune response, acti-
vated by IIR through specific signals. AIR is made up of T
and B lymphocytes (Fig. 1), where B lymphocytes are involved
in humoral while T lymphocytes are involved in cell mediated
cell response. The T lymphocytes act through receptors (TCR)
and B lymphocytes respond through antibodies. These special-
ized cells are involved in the elimination and prevention of the
growth of pathogens. IIR and AIR responses are given
through blood and physical barriers and both immunities cor-
respond with each other through cytokines (Interleukins,
Interferon’s and growth factors), chemicals and hormones [2].
2. Immune system and cancer
Cancer is a disease initiated by a series of collective genetic and
epigenetic changes in a normal cell. In addition to the malig-
nant cell itself, cancer is a disease of micro environment and
immunity [3]. The immune system (IS) and tumor cells are
often concurrent in a dynamic equilibrium and both have a
complex interaction and are interlinked [4]. Tumor has the
capacity to resist the IS in order to proliferate but in response,
the IS has the ability to control the growth of proliferating
tumor cells. According to the theory of immune surveillance,
the IS works for cancers on the basis of three stages such as
exclusion, equilibrium and escape [5]. In exclusion (elimina-
tion) stage, cancer is recognized and destroyed by the IS. In
equilibrium stage, IS wipes out the cancer cells completely.
In escape stage, the IS remains unable to control the growth
of proliferating cancerous cells and cannot demolish the
tumor. In cancer, the IS is mostly pathetic due to the use of
radiotherapy and chemotherapy, so research has been con-
ducted in recent years to boost immunity and immunotherapy
is carried out to treat cancer [6].
3. Role of Natural killer cells
Natural killer (NK) cells were first discovered in humans and
mice in 1975 and are large granular population of leukocytes,
that can directly kill the virus infected or tumor cells [4]. NKTable 1 Function of natural killer cells in humans triggered
by cytokines, receptor and ligands. TLR: tool like receptor,
TGF: tumor growth factor, Ly49A: type II transmembrane
molecule, KIR: immunoglobulin like receptors, MICA: MHC-
1 related ligand, HLA: human leukocyte antigen.
Activator Inhibitor Receptors Ligands Cytotoxicity
TLR ligand IL-10 NKG2A HLA IL-2
IFN-a/b TGF-b NKG2D MICA IL-12
IL-2 MHC-1 CD16 IgG IL-15
IL-12 KIR NKp30 Tumor IL-18
IL-15 Ly49A NKp44 Tumor IL-25
IL-18 Tumor NKp46 Tumor IFN-ccells of the immune system specially lyse the tumor cells and
virus infected cells [7]. A recent analysis suggested the response
of NK cells based on the expression of major histo-
compatibility complex class-1 (MHC-1) molecules and induci-
ble ligand of NK cell receptor [8]. NK cells play an important
role in the immune surveillance of cancer and are accom-
plished to prevent the growth of tumor [9,10]. They have the
ability to recognize targets directly through inhibitory or acti-
vating receptors expressed on the cell surface of tumor or other
target cells [11]. The ligand on the surface of target cells
(infected or tumor cells) triggers NK cell cytotoxicity and acti-
vates the receptors of NK cells. These ligands are absent on the
surface of normal cells. NK cells modulate activity of other
leukocytes such as dendritic cells (DCs) and T cells through
cytokine. A recent study reported that NK cell derived
Interferon-c (IFN-c) promotes macrophages toward tumor
and defends the organism from carcinogen induction [12].
4. Mechanism involved in the lysis of tumor by NK cells
Generally the NK cells are activated by different stimuli such
as contact to the dendritic cells, MHC-1 negative cells, prod-
ucts derived by the infectious agents, direct involvement of
NKR by stress induced tumor molecules, various cytokines
such as IL-1, IL-2, IL-12, IL-15, IL-18, IL-21, and type I IFNs.
On the stimulation of cytokine, the NK cells are converted into
lymphokine-activated killer (LAK) cells. These LAK cells
propagate, produce cytokines and up-regulate the effectors
or adhesion molecules like perforin, NKp44, granzymes, Fas
ligand (FasL), and TRAIL. These LAK cells adhere to the tar-
get cells and recognize them and increase tumor lysis activity
[13–15]. Tumor necrosis factor (TNF) family ligands express
themselves on the surface of NK cells. NK cells control the
tumor by continued T cell antitumor response through cross
talk with dendritic cells [16]. Evidence showed that cytokines
such as IL-2, IL-15, IL-12, IL-18, (see Table 1) and CD40
enhance NK cell cytotoxicity against tumor target cells and
the production of IFN-c by NK cells [17]. IFN-c and CD40
play an important role in the stimulation of dendritic cells
and provoke IL-12 from dendritic cells [18].
5. Granzyme B
Previous studies reported that Granzyme B (GrB) is generated
by NK cells and cytotoxic T lymphocytes (CTL) in an inactive
form and contains N-terminal signal dipeptide (Glycine-
Glucan). The cysteine protease creates activity of the GrB by
removing the dipeptide. Perforin is released and binds to the
cell membrane of tumor cells and causes the conformational
changes to form the pores in the cell membrane. GrB deriva-
tives are interacted with tumor cell surface antigen (EGFR
or ErbB2), and by these pores GrB cross the threshold and
enter into the cytosol of the target cells and induce apoptosis
[19]. Research revealed that cancer increases expression of
major histocompatibility complex class-1 (MHC-1) [20] in
order to inhibit NK cell cytotoxicity and suppress the expres-
sion of NKG2D, which spoils the recognition of NK cells [21].
Previous studies reported that treatment with GrB-scFv pro-
teins sensitized tumor to radiation and chemotherapy [22], so
in future the mechanism of GrB requires further analysis. A
recent study in humans reported that administration of IL-15
152 F. Nouroz et al.enhanced the activity of NK cells [23]. Another analysis
showed that clinically mutual administration of IL-2, IL-15
in mice increased the efficiency of antitumor immunity in
carcinoma [24].
6. Cancer stem cells
Cancer stem cells (CSCs) retain the growth of tumor and resist
chemotherapy [25]. NK cells can target CSCs and are talented
targets for immunotherapy in future [26]. Previous studies
suggested that tumors resist immunity through dominant
inhibitory effects of the immune system. The prospect of
immunotherapy for cancer is now becoming a clinical reality.
Besides a new approach of databases predicting the character
peptide epitopes to definite MHC molecules (e.g. human
leukocyte antigen-A2; HLA-A2) has been recognized. In the
course of bioinformatics, the background of mutatopes for
entity cancers is becoming a reality [27].
7. NK cells increase the cytotoxicity of tumor cells by natural
products
Previous studies suggested that natural products increase the
cytotoxic activities of NK cells and increased the level of tumor
necrosis factor alpha (TNF-a) while decreasing the DNA dam-
age in patients with late stage cancer. Studies confirmed that
clinical results can be improved by a combination of nutraceu-
ticals. Twenty patients of stage IV (bladder, breast, prostate,
lung, neuroblastoma, mesothelioma, lymphoma, ovarian, gas-
tric and osteosarcoma) cancer were treated with natural prod-
ucts such as transfer factor plus, immune modulator mix,
ascorbic acid, IMU plus, Agaricus blazei teas, nitrogenated
soy extract and Andrographis paniculata. After nutrients appli-
cation, the function of NK cells and TNF-a and receptor levels
were measured by phytohemagglutinin (PHA) and ELISA.
Complete blood count and chemistry panels were daily
counted. After 6 months, 16 of the 20 patients were alive,
which showed maximum efficiency of NK cell function and
TNF-a level in all four cell population. It was observed that
hemoglobin, hematocrit and glutathione levels were prominent
in investigated patients. It concluded that an aggressive combi-
nation of immuno-active nutraceuticals was effective in late
stage cancer; while the clinical outcome evaluations are ongo-
ing [28].
7.1. Mushrooms enhance NK cell mediated cytotoxicity
Study confirmed that beta glucans derived from solid cultures
of Ganoderma lucidum (Lingzhi or Reishi) enhances NK cell
mediated cytotoxicity in lung carcinoma in mice with radiation
therapy only or in conjunction with radio therapy. It is more
effective in controlling the growth of tumor and metastasis, pre-
vents hair loss and healing of the wounds in tumor infected
mice. The experiment conducted on 40 mice indicated that
the mice treated only with radiation showed the highest number
of metastatic tumor nodules (nodules = 17), the mice treated
with mushroom beta glucans showed less number of metastatic
tumor nodules (nodules = 2) and the mice treated with both
radiation therapy and mushroom beta glucans showed only 1
nodule. The experiments on mice having cancer suggested that
cytotoxicity of NK cells might be increased by natural products[29]. G. lucidum stimulates immunity through NK cell cytotox-
icity. The results of the clinical trial suggested that it displayed
potential immune-modulating effect in patients with advanced
colorectal cancer. Although, these results showed its anti-
cancerous activities but further investigations are required to
explore the benefits of G. lucidum [30]. The A. blazei and its
extracts are also reported to be used as cancer alternative
medicines (CAMs). It increased the cytotoxicity of NK cells
in wild type (WT) C57BL/6, C3H/HeJ, BALB/c and RAG-2
deficient mice but not from IFN-deficient mice. NK cell activa-
tion and IFN-c production were also observed in vitro when
DC rich splenocytes of wild type mice were co-incubated with
an extract of A. blazei. These observations demonstrated that
A. blazei increased NK cell activation through IL-12 mediated
IFN-c production [30].
7.2. Alternative phytochemicals used against cancer
Study on various plant constituents revealed that most of the
phytochemicals are widely used as immune modulators against
cancer or tumors. The important anti-cancerous natural plant
products (phytochemicals) are Apigenin from parsley, crocetin
from saffron, curcumin from turmeric, cyanidins from grapes,
cranberries, raspberries, etc, Epigallocatechin gallate from
green tea, fisetic from strawberries, apples, diindolylmethane
(DIM) from Brassica vegetables, genistein from soybean, gin-
gerol from gingers, kaempferol from grapefruit, tea, broccoli,
Lycopene from tomato, resveratrol from grapes, sulforaphane
from cruciferous vegetables, rosmarinic acid from rosemary,
vitamin D from mushrooms and vitamin E from various plant
oils [31].
8. NK cells and tumor immunotherapy
In previous studies, where NK cells were used in tumor ther-
apy, NK cells were incubated in the presence of human and
mouse tumor cell lines. The expanded NK cells were identified
by physical parameters. Human NK cells expand in response
to stimulation with varied tumor cell lines. Tumor derived
expansion of NK cells is accompanied by rapid changes in
CD16 expression levels, MHC class-l negative tumor cell line
and to the EBV transformed cell line 721.221. CD16 expres-
sion was maintained on the cell surface of the expanded NK
cells due to antibody dependent mechanism. If the antibodies
are present against the tumor cells in the patients, it might
be beneficial to expand the NK cells in the presence of 1106
mel cells. The selective expansion of NK cells was used for
tumor immunotherapy [32]. A recent study used whole genome
microarray data sets of the Immunological Genome Project
and demonstrated that there was a close relationship between
NK cells and T cells than other leukocytes because these cells
shared expression of gene encoding molecules with similar sig-
naling functions. Resting NK cells are known to share expres-
sion of genes with cytotoxic CD8+ T cells, which allow NK
cells to respond more rapidly to viral infection [33]. The role
of Treg cells in tumor immunological response is investigated
in several previous studies. These regulatory T cells (Treg cells)
are involved in promoting various types of tumors. The tumor
cells recruit and generate the Treg cells to create a suppressive
tumor microenvironment. The antitumor activity of T cells
and NK cells is inhibited by Treg cells. Experimental and clin-
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tion strategies of Treg cells yielded highly efficient results in
enhancing anti-tumor immunity [34]. Recently the therapeutic
approaches to enhance the cytotoxicity of the NK cells against
cancer have been investigated. The study revealed that
advancements in scientific discoveries for pathways of activat-
ing NK cells efficiency against tumor have led to the develop-
ment of genetic and pharmacological techniques, which
enhanced the antitumor properties of NK cells. It also allowed
the investigators with several new strategies to connect the
potential of NK cell based immunotherapy in the clinical stud-
ies [35].
9. Conclusion
The NK cells not only exhibit cytotoxic activities against
tumor cells but also activate other immune cells against cancer
cells. It takes part in adaptive immunity through cytokines and
is a brilliant target for immunotherapy in future treatment due
to its direct or indirect target to tumor cells. Natural products
(nutraceuticals), alternative medicines, immune modulators
and active hexose correlated compounds enhance the activity
of NK cells. Further investigations are required to study the
effect of NK cells on various cancers and how the affect of
these NK cells can be enhanced.
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